These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2454064)
1. Vascular effects of neuropeptides on nasal mucosa. Ichimura K; Mineda H; Seki A Ann Otol Rhinol Laryngol; 1988; 97(3 Pt 1):289-93. PubMed ID: 2454064 [TBL] [Abstract][Full Text] [Related]
2. Peptidergic control of gastrointestinal blood flow in the estuarine crocodile, Crocodylus porosus. Kagstrom J; Olsson C; Axelsson M; Franklin CE Am J Physiol; 1998 Jun; 274(6):R1740-50. PubMed ID: 9841548 [TBL] [Abstract][Full Text] [Related]
3. Neuropeptides with vascular activity: VIP, PHI, NPY and substance P. Lundberg JM; Hökfelt T; Anggård A; Lundblad L; Saria A; Fahrenkrug J; Terenius L Bibl Cardiol; 1984; (38):60-9. PubMed ID: 6085266 [No Abstract] [Full Text] [Related]
4. Effects of some peptides on isolated human penile erectile tissue and cavernous artery. Hedlund H; Andersson KE Acta Physiol Scand; 1985 Jul; 124(3):413-9. PubMed ID: 2413712 [TBL] [Abstract][Full Text] [Related]
5. Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium. Pernow J Br J Pharmacol; 1989 Jul; 97(3):983-9. PubMed ID: 2474355 [TBL] [Abstract][Full Text] [Related]
6. Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT. Rigel DF Am J Physiol; 1988 Aug; 255(2 Pt 2):H311-7. PubMed ID: 3261545 [TBL] [Abstract][Full Text] [Related]
7. Sympathetic vascular control of the pig nasal mucosa (2): Reserpine-resistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP. Lacroix JS; Stjärne P; Anggård A; Lundberg JM Acta Physiol Scand; 1988 Jun; 133(2):183-97. PubMed ID: 3227914 [TBL] [Abstract][Full Text] [Related]
8. Adrenergic and non-adrenergic vasoconstrictor mechanisms in the human nasal mucosa. Fischer L; Auberson S; Bretton C; Lacroix JS Rhinology; 1993 Mar; 31(1):11-5. PubMed ID: 8100640 [TBL] [Abstract][Full Text] [Related]
9. Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Jansen I; Uddman R; Hocherman M; Ekman R; Jensen K; Olesen J; Stiernholm P; Edvinsson L Ann Neurol; 1986 Oct; 20(4):496-501. PubMed ID: 2431650 [TBL] [Abstract][Full Text] [Related]
10. Demonstration of neuropeptide containing nerves and vasomotor responses to perivascular peptides in human cerebral arteries. Edvinsson L; Jansen I; Cunha e Sa M; Gulbenkian S Cephalalgia; 1994 Apr; 14(2):88-96. PubMed ID: 7520366 [TBL] [Abstract][Full Text] [Related]
12. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide. Modin A Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267 [TBL] [Abstract][Full Text] [Related]
13. The role of neuropeptides in the regulation of adrenal vascular tone: effects of vasoactive intestinal polypeptide, substance P, neuropeptide Y, neurotensin, Met-enkephalin, and Leu-enkephalin on perfusion medium flow rate in the intact perfused rat adrenal. Hinson JP; Cameron LA; Purbrick A; Kapas S Regul Pept; 1994 Apr; 51(1):55-61. PubMed ID: 7518603 [TBL] [Abstract][Full Text] [Related]
14. Inotropic effects of calcitonin gene-related peptide, vasoactive intestinal polypeptide and somatostatin on the human right atrium in vitro. Franco-Cereceda A; Bengtsson L; Lundberg JM Eur J Pharmacol; 1987 Jan; 134(1):69-76. PubMed ID: 2881795 [TBL] [Abstract][Full Text] [Related]
15. Sympathetic and parasympathetic interaction in vascular control of the nasal mucosa in anaesthetized cats. Lacroix JS; Ulman LG; Potter EK J Physiol; 1994 Oct; 480 ( Pt 2)(Pt 2):325-31. PubMed ID: 7869247 [TBL] [Abstract][Full Text] [Related]
16. The role of neuropeptides in the regulation of adrenal zona fasciculata/reticularis function. Effects of vasoactive intestinal polypeptide, substance P, neuropeptide Y, Met- and Leu-enkephalin and neurotensin on corticosterone secretion in the intact perfused rat adrenal gland in situ. Hinson JP; Purbrick A; Cameron LA; Kapas S Neuropeptides; 1994 Jun; 26(6):391-7. PubMed ID: 7523979 [TBL] [Abstract][Full Text] [Related]
17. Smooth muscle dilatation in the human uterine artery induced by substance P, vasoactive intestinal polypeptide, calcitonin gene-related peptide and atrial natriuretic peptide: relation to endothelium-derived relaxing substances. Bodelsson G; Stjernquist M Hum Reprod; 1992 Oct; 7(9):1185-8. PubMed ID: 1282518 [TBL] [Abstract][Full Text] [Related]
19. The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog. Corder R; Lowry PJ; Withrington PG Br J Pharmacol; 1987 Apr; 90(4):785-90. PubMed ID: 3580708 [TBL] [Abstract][Full Text] [Related]
20. Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo. Wolzt M; Gerschlager W; Zweytick B; Jilma B; Riemer H; Sertl K; Eichler HG Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):194-200. PubMed ID: 7990977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]